Leukemic transformation of polycythemia vera
Open Access
- 26 July 2005
- Vol. 104 (5), 1032-1036
- https://doi.org/10.1002/cncr.21297
Abstract
BACKGROUND Acute leukemia (AL) may occur as rare and late event of polycythemia vera (PV). METHODS The current study included 23 patients who developed acute leukemia in a cohort of 414 consecutive PV patients with long-term observation (3208 person years of follow-up). Kaplan–Meier Product-Limit method was used to estimate the cumulative probability of survival; Gehan–Wilcoxon test was applied to compare survival in different groups of patients. RESULTS Median age was 68 years, and 18 patients (78%) were > 60 years of age. At diagnosis of AL, most patients had a white blood count > 10 × 109/L (n = 17; 74%), Hgb < 10 g/dL (n = 13; 57%), and platelet count > 50 × 109/L (n = 17; 74%). Of 14 patients in whom cytogenetic analysis was available at leukemic transformation, 12 showed high-risk abnormalities including complex karyotype (n = 10), del (7)(q22) sole (n = 1) and del (X)(q26) sole (n = 1), whereas 2 had a normal karyotype. In patients whose karyotype was available at diagnosis of PV, cytogenetic evolution was documented at progression to AL. Treatment consisted of supportive care and/or low-dose chemotherapy (n = 15), or induction chemotherapy (n = 8). This included idarubicin plus cytarabine (n = 3), high-dose cytarabine (n = 4), and fludarabine-based regimen (n = 1). Allogenic stem cell transplantation was offered to a single patient, who is alive at Day + 70. The outcome of patients was poor, with a median survival of 2.9 months (range, 0.6–20.1 mos), with no significant differences between palliation and intensive treatments. CONCLUSIONS AL following PV has distinct clinical and biologic features. Outcome of patients is poor irrespective of the treatment employed. Cancer 2005. © 2005 American Cancer Society.Keywords
This publication has 24 references indexed in Scilit:
- Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasiaBlood, 2005
- Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational studyBlood, 2005
- Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 casesBlood, 2005
- Beyond chronic myelogenous leukemiaCancer, 2004
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- Therapy‐related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992British Journal of Haematology, 2001
- Acute Myeloid LeukemiaThe New England Journal of Medicine, 1999
- Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome: A multicenter study of 55 patientsCancer Genetics and Cytogenetics, 1988
- Acute leukemia and myelodysplasia in polycythemia vera.A clinical study with long-term follow-upCancer, 1988
- Polycythaemia Vera Terminating in Acute Leukaemia A Clinical, Cytogenetic and Morphologic Study in 8 Patients Treated with Alkylating AgentsScandinavian Journal of Haematology, 1977